Results 1 to 10 of about 39,176 (275)
Infections associated with clozapine: a pharmacovigilance study using VigiBase®
Introduction: Clozapine is primarily reserved for treatment-resistant schizophrenia due to safety concerns associated with its use. Infections have been reported with clozapine, which may lead to elevated serum levels of the drug.
Basile Chrétien +11 more
doaj +1 more source
An evaluation of the variation and underuse of clozapine in the United Kingdom [PDF]
Background Clozapine is the only licensed treatment for treatment refractory schizophrenia. Despite this, it remains grossly underused relative to the prevalence of refractory schizophrenia.
Sukhwinder S. Shergill +5 more
core +1 more source
Supplemental material, sj-jpeg-1-tpp-10.1177_20451253211072341 for Clozapine- and non-clozapine-associated neutropenia in patients with schizophrenia: a retrospective cohort study by Claas-Frederik Johannsen, Tonny Studsgaard Petersen, Jimmi Nielsen ...
Anders Fink-Jensen (724822) +5 more
core +1 more source
Reasons for admission to a general medical hospital for patients taking clozapine
Background: Clozapine is associated with a diverse range of side effects. In addition, patients prescribed clozapine commonly suffer with medical comorbidities.
Siobhan Gee +4 more
doaj +1 more source
Patterns of clozapine use, misuse and disuse in a mental health area in southern Spain
Introduction Evidence supports clozapine as the best treatment in terms of efficacy, effectiveness and well-being, and as the gold standard in treatment-resistant psychotic disorders. Clozapine remains still underused, suffering initiation delays from 1.
L.I. Muñoz-Manchado +7 more
doaj +1 more source
Clozapine treatment during the COVID-19 pandemic
Introduction Clozapine is an effective antipsychotic used in treatment-resistant schizophrenia. One of the serious complications of clozapine therapy is agranulocytosis, therefore regular monitoring of the level of white blood cells (WBC) in plasma is ...
E. Dąbrowska +3 more
doaj +1 more source
Clozapine-induced myocarditis in children (age ≤18 yo) was studied from a PubMed search (18 July 2022) (9 cases) and from the World Health Organization’s pharmacovigilance database, called Vigibase, of adverse drug reaction (ADR) reports (72 non ...
Jose de Leon (4242862) +5 more
core +1 more source
Change in plasma concentration of clozapine and norclozapine following a switch of oral formulation
Background: Clozapine formulation has been shown to affect plasma concentrations of clozapine and norclozapine. Changes in formulation might result in toxicity or treatment failure.
Farinaz Keshavarzi +3 more
doaj +1 more source
Factors predicting serum clozapine levels in Middle Eastern patients: an observational study
Background Despite its superiority over other drugs for psychosis, clozapine remains underused and is associated with many clinical challenges, including difficulties in predicting therapeutic serum levels (350-600 ng/mL).
Ahmed Hassab Errasoul +1 more
doaj +1 more source
Setting up a clozapine service for Parkinson's psychosis
Parkinson's psychosis can be very challenging to manage, with limited treatment options available. There is a good evidence base to support the use of clozapine, but practical obstacles often prevent its use.
Marsh-Davies, Alison +4 more
core +1 more source

